Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV
Clinical trial NCT01003964 · COMPLETED
Trial details
- NCT number
- NCT01003964
- Sponsor
- National Cancer Center, Korea
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2015-06-01
- Enrollment
- 289
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.